Intelligence Β· Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
prucalopride
Takeda
Chronic Constipation
1 trial -
quetiapine fumarate tablet (Seroquel)
The First People's Hospital of Lianyungang
Bipolar Disorder
1 trial -
rFVIIIFc
Sanofi Pasteur
Hemophilia A With Inhibitors
1 trial -
ramelteon
Takeda
Migraine Headache
1 trial -
recombinant human erythropoietin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Birth
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
recombinant human hyaluronidase
HALOZYME THERAPEUTICS, INC.
Healthy
1 trial -
recombinant human thrombopoietin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombocytopenia
1 trial -
rhGM-CSF group
Biotech Pharmaceutical Co.,
Mycoses
1 trial -
rhGM-CSF group
The First People's Hospital of Lianyungang
Mycoses
1 trial -
rhPTH (1-84)
Takeda
Hypoparathyroidism
3 trials -
rhPTH(1-84)
Takeda
Chronic Hypoparathyroidism
2 trials -
rhTPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Previously Treated Primary Immune Thrombocytopenia
1 trial -
rhTPO
The First People's Hospital of Lianyungang
Thrombocytopenia
1 trial -
rhTPO
The First People's Hospital of Lianyungang
Primary Immune Thrombocytopenia
1 trial -
risedronate sodium
Sanofi Pasteur
Osteoporosis, Postmenopausal
1 trial -
risperidone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Neuroleptic-Induced Tardive Dyskinesia
1 trial -
rituximab combined with corticosteroids
The First People's Hospital of Lianyungang
Primary Membranous Nephropathy
1 trial -
ropivacaine
The First People's Hospital of Lianyungang
Injury of Upper Limb
1 trial -
rt-PA
Takeda
Lacunar Stroke
1 trial -
sIPV
Sinovac Research and Development Co.,
Poliomyelitis
3 trials -
sIPV vaccine /DTaP vaccine
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
sIPV+DTaP+HepA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Vaccination
1 trial -
sIPV+DTaP+MMR
BRIGHT MINDS BIOSCIENCES INC.
Vaccine
1 trial -
saproterin dihydrochloride
BioMarin Pharmaceutical Australia Pty Ltd
Phenylketonuria
1 trial -
seasonal split influenza vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
semaglutide combined with metformin
The First People's Hospital of Lianyungang
Osteoporosis
1 trial -
silk suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
sodium iodide
United Therapeutics Europe Ltd
Transient Hypothyroxinemia
1 trial -
sodium oxybate
Jazz Pharmaceuticals Ireland Limited
Sleep
1 trial -
sodium valproate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
sodium zirconium cyclic silicate
The First People's Hospital of Lianyungang
Potassium Imbalance
1 trial -
split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose
Sinovac Research and Development Co.,
Influenza
1 trial -
sublingual nicotine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain, Acute Postoperative
1 trial -
tacrolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Moderate/Severe Atopic Dermatitis
1 trial -
tacrolimus
Chinese University of Hong Kong
Lupus Nephritis
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial -
telbivudine (ROADMAP)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
telmisartan
Boehringer Ingelheim
Hypertension
1 trial -
temsirolimus
Pfizer
Non-Hodgkin's Lymphoma
1 trial -
theophylline
Takeda
Healthy
1 trial -
ticagrelor
The First People's Hospital of Lianyungang
Inflammation
1 trial -
ticagrelor + ASA
Peking University Third Hospital
Cerebrovascular Accident
1 trial -
tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer
Appendicitis
1 trial -
tiotropium 18 mcg
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
1 trial -
tong-jiang granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome
1 trial -
transdermal nicotine replacement therapy
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs